StockData
Boston Scientific Corp logo

Boston Scientific Corp

BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3048% below fair value
$43.64+0.61 (+1.42%)

Close on Nov 18, 2026Market cap $63.24BP/E 17.7Yield –

Boston Scientific NIH ClinicalTrials.gov by Quarter

NIH ClinicalTrials.gov — Boston Scientific Studies Started in Period (studies)

Boston Scientific NIH ClinicalTrials.gov: 11.00 studies in Q3 2026, up 37.5% from a year earlier.

Latest, Q3 2026
11.00
Period ended Sep 30, 2026
Change on a year earlier
+37.5%
8.00 in Q3 2025
History
47 quarters
Since Q1 2015
Sources
1
NIH ClinicalTrials.gov Registry — Boston Scientific

Where the Q3 2026 figure comes from

Source: NIH ClinicalTrials.gov Registry — Boston Scientific ↗

Reported in U.S. National Library of Medicine (ClinicalTrials.gov API v2 — Boston Scientific Sponsored Studies).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNIH ClinicalTrials.gov — Boston Scientific Studies Started in Period (studies)Year on yearSource
Q3 2026Sep 30, 202611.00+37.5%NIH ClinicalTrials.gov Registry — Boston Scientific ↗
Q2 2026Jun 30, 202611.00-8.3%NIH ClinicalTrials.gov Registry — Boston Scientific ↗
Q1 2026Mar 31, 20269.00-10.0%NIH ClinicalTrials.gov Registry — Boston Scientific ↗
Q4 2025Dec 31, 202510.00+25.0%NIH ClinicalTrials.gov Registry — Boston Scientific ↗
Q3 2025Sep 30, 20258.00+60.0%NIH ClinicalTrials.gov Registry — Boston Scientific ↗
Q2 2025Jun 30, 202512.000.0%NIH ClinicalTrials.gov Registry — Boston Scientific ↗
Q1 2025Mar 31, 202510.00+25.0%NIH ClinicalTrials.gov Registry — Boston Scientific ↗
Q4 2024Dec 31, 20248.00-11.1%NIH ClinicalTrials.gov Registry — Boston Scientific ↗
Q3 2024Sep 30, 20245.00+66.7%NIH ClinicalTrials.gov Registry — Boston Scientific ↗
Q2 2024Jun 30, 202412.00+300.0%NIH ClinicalTrials.gov Registry — Boston Scientific ↗
Q1 2024Mar 31, 20248.00-27.3%NIH ClinicalTrials.gov Registry — Boston Scientific ↗
Q4 2023Dec 31, 20239.00-18.2%NIH ClinicalTrials.gov Registry — Boston Scientific ↗
Q3 2023Sep 30, 20233.00-66.7%NIH ClinicalTrials.gov Registry — Boston Scientific ↗
Q2 2023Jun 30, 20233.000.0%NIH ClinicalTrials.gov Registry — Boston Scientific ↗
Q1 2023Mar 31, 202311.00+57.1%NIH ClinicalTrials.gov Registry — Boston Scientific ↗
Q4 2022Dec 31, 202211.00+22.2%NIH ClinicalTrials.gov Registry — Boston Scientific ↗

Breakdown

What makes up NIH ClinicalTrials.gov

Cite this data

StockData. (2026). Boston Scientific NIH ClinicalTrials.gov, quarterly Q1 2015–Q3 2026 [Data set]. Compiled from Boston Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/bsx/kpis/ext-ct-started

See every metric in the Boston Scientific KPI table. Data updated Nov 4, 2026.

See a number that looks wrong?